Literature DB >> 28374238

Antioxidant effects of rice bran oil mitigate repeated haloperidol-induced tardive dyskinesia in male rats.

Noreen Samad1, Darakhshan Jabeen Haleem2.   

Abstract

Tardive dyskinesia (TD) is associated with the use of antipsychotic drugs such as D2 antagonist haloperidol (HP). The chronic use of HP is involved in the causation of free radicals and/or oxidative stress. In view of the nootropic, anti-anxiety, anti-inflammatory-like effects of rice bran oil (RBO) in a variety of investigations, we assessed the protective properties of RBO on HP-induced TD and neurochemical alteration. Rats treated with HP orally at a dose of 0.2 mg/kg/day for a period of 5 weeks developed VCMs which increased progressively as the treatment continued for 5 weeks. Co-administration of RBO by oral tubes at a dose of 0.4 ml/day prevented the induction of HP-induced VCMs. Repeated administration of HP increases the turnover of dopamine metabolism in the striatum. Conversely animals treated with HP + RBO decrease the metabolism of DA than water + HP treated animals. Striatal, malondieldehyde (MDA), hydrogen peroxide (H2O2) and antioxidant enzyme superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPx) were also determined. It is suggested that beneficial role of RBO in attenuation of HP-induced TD. The results therefore recommended that supplementation of RBO may be useful in the HP-induced TD. The findings have also potential implication in the treatment of schizophrenia and motor disorders.

Entities:  

Keywords:  DA metabolism; Haloperidol; Oxidative stress; RBO; TD

Mesh:

Substances:

Year:  2017        PMID: 28374238     DOI: 10.1007/s11011-017-0002-8

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  45 in total

1.  Hydrogen peroxide production in dopamine neurons.

Authors:  M B Spina; G Cohen
Journal:  Basic Life Sci       Date:  1988

Review 2.  Free radical pathology and antioxidant defense in schizophrenia: a review.

Authors:  S P Mahadik; S Mukherjee
Journal:  Schizophr Res       Date:  1996-03       Impact factor: 4.939

Review 3.  Oxygen radicals and neuropsychiatric illness. Some speculations.

Authors:  J B Lohr
Journal:  Arch Gen Psychiatry       Date:  1991-12

4.  Invivo antioxidant status: a putative target of antidepressant action.

Authors:  Ayesha Zafir; Anjum Ara; Naheed Banu
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2008-11-30       Impact factor: 5.067

5.  S100B-immunopositive glia is elevated in paranoid as compared to residual schizophrenia: a morphometric study.

Authors:  Johann Steiner; Hans-Gert Bernstein; Hendrik Bielau; Nadine Farkas; Jana Winter; Henrik Dobrowolny; Ralf Brisch; Tomasz Gos; Christian Mawrin; Aye Mu Myint; Bernhard Bogerts
Journal:  J Psychiatr Res       Date:  2007-11-14       Impact factor: 4.791

6.  The incidence of metabolic syndrome and its reversal in a cohort of schizophrenic patients followed for one year.

Authors:  S G Schorr; C J Slooff; R Bruggeman; K Taxis
Journal:  J Psychiatr Res       Date:  2009-04-26       Impact factor: 4.791

7.  An o-quinone form of estrogen produces free radicals in human breast cancer cells: correlation with DNA damage.

Authors:  L M Nutter; Y Y Wu; E O Ngo; E E Sierra; P L Gutierrez; Y J Abul-Hajj
Journal:  Chem Res Toxicol       Date:  1994 Jan-Feb       Impact factor: 3.739

8.  Neuropsychological function and dysfunction in schizophrenia and psychotic affective disorders.

Authors:  Abraham Reichenberg; Philip D Harvey; Christopher R Bowie; Ramin Mojtabai; Jonathan Rabinowitz; Robert K Heaton; Evelyn Bromet
Journal:  Schizophr Bull       Date:  2008-05-20       Impact factor: 9.306

9.  Harmine and imipramine promote antioxidant activities in prefrontal cortex and hippocampus.

Authors:  Gislaine Z Réus; Roberto B Stringari; Bruna de Souza; Fabrícia Petronilho; Felipe Dal-Pizzol; Jaime E Hallak; Antônio W Zuardi; José A Crippa; João Quevedo
Journal:  Oxid Med Cell Longev       Date:  2010-09-01       Impact factor: 6.543

10.  Coadministration of Resveratrol and Rice Oil Mitigates Nociception and Oxidative State in a Mouse Fibromyalgia-Like Model.

Authors:  Caroline Peres Klein; Marcos Rodrigues Cintra; Nancy Binda; Danuza Montijo Diniz; Marcus Vinicius Gomez; Andre Arigony Souto; Alessandra Hubner de Souza
Journal:  Pain Res Treat       Date:  2016-03-16
View more
  4 in total

1.  Biochemical Pathways Triggered by Antipsychotics in Human [corrected] Oligodendrocytes: Potential of Discovering New Treatment Targets.

Authors:  Caroline Brandão-Teles; Valéria de Almeida; Juliana S Cassoli; Daniel Martins-de-Souza
Journal:  Front Pharmacol       Date:  2019-03-05       Impact factor: 5.810

Review 2.  Antioxidant Properties of Second-Generation Antipsychotics: Focus on Microglia.

Authors:  Giuseppe Caruso; Margherita Grasso; Annamaria Fidilio; Fabio Tascedda; Filippo Drago; Filippo Caraci
Journal:  Pharmaceuticals (Basel)       Date:  2020-12-12

Review 3.  Genetic Factors Associated With Tardive Dyskinesia: From Pre-clinical Models to Clinical Studies.

Authors:  Evangelia Eirini Tsermpini; Sara Redenšek; Vita Dolžan
Journal:  Front Pharmacol       Date:  2022-01-24       Impact factor: 5.810

4.  Correlation of Blood Biochemical Markers with Tardive Dyskinesia in Schizophrenic Patients.

Authors:  Qian Wu; Fengjuan Yuan; Shuo Zhang; Weiting Liu; Qing Miao; Xinhua Zheng; Suxiang Lu; Kaijian Hou
Journal:  Dis Markers       Date:  2022-03-08       Impact factor: 3.434

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.